GlaxoSmithKline plc, Ortho Dermatologics (a division of Bausch Health Companies Inc.), and FOUNDATION CONSUMER HEALTHCARE are Dominating the Global Cold Sore Treatment Market in 2021

Global Cold Sore Treatment Market is expected to grow with the CAGR of 6.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-cold-sore-treatment-market

Global cold sore treatment market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favorable market scenario.

The major players dealing in global cold sore treatment market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, in December 2020, 2020, GlaxoSmithKline plc and Sanofi Inc had declared the delay in the adjuvant recombinant protein based COVID-19 vaccine programme to enhance immune response in the elderly population. This initiative by both the companies would result in delay of the cold sore treatment products, less revenue and less growth in the market.

GlaxoSmithKline plc is dominating player in global cold sore treatment market. The other key players existing in the market includes Merix Pharmaceutical Corp.,Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc., U.S.A. (A Subsidiary of Glenmark Pharmaceuticals Ltd.), Zydus Pharmaceuticals, Inc.(A Subsidiary of Zydus Cadila), Cipla Inc., AiCuris GmbH & Co. KG, Ortho dermatologics’ (a division of bausch health Companies Inc.), Foundation Consumer Healthcare, Squarex, Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.), Aurobindo Pharma U.S.A. (A Subsidiary of Aurobindo Pharma), WOCKHARDT, Novartis AG, Jubilant Cadista (a subsidiary of Jubilant Life Sciences Limited), Hikma Pharmaceuticals PLC, Hetero Healthcare Limited, Apotex Inc., Avanir Pharmaceuticals, Inc., HRA Pharma among others.

Cold Sore Treatment Market GlaxoSmithKline plc

GlaxoSmithKline plc headquartered in Brentford, U.K. The company is focused on delivery of strategic properties which aims to improve growth, reduce risk, and improve long term financial performance. The company deals in multiple products such as pharmaceuticals, vaccines and consumer healthcare products out of which consumer healthcare product is the market focused product portfolio.

  • In December 2020, GlaxoSmithKline plc and Sanofi Inc had declared the delay in the adjuvant recombinant protein based COVID-19 vaccine programme to enhance immune response in the elderly population. This initiative by both the companies would result in delay of the cold sore treatment products, less revenue and less growth in the market.

The company has global presence in North America, Europe, Asia Pacific, Middle East & Africa and South America. The company has many subsidiaries such as GlaxoSmithKline Pharmaceuticals Ltd (Mumbai), Tesaro (Waltham, Massachusetts, United States), GlaxoSmithKline Pakistan (Karachi, Pakistan), Stiefel Laboratories (North Carolina, United States), Allen & Hanburys (Ware, United Kingdom), among others.

Ortho Dermatologics (a division of Bausch Health Companies Inc.)

Ortho Dermatologics (a division of Bausch Health Companies Inc.) is headquartered in New Jersey, the U.S. The company focusses on dermatology field through their honest actions and ongoing heritage of helping improve patients' live. The company has multiple products & solution categories such as ALTRENO, ARAZLO, BRYHALI, CLINDAGEL, DUOBRII, ELIDEL, JUBLIA, LOCOID LOTION, LOPROX SHAMPOO, LUZU, NORITATE, ONEXTON, RETIN-A MICRO, SILIQ, SOLODYN, XERESE, ZIANA, ZOVIRAX, ZYCLARA out of which ALTRENO, ZOVIRAX, XERESE are the market focused category.

  • In February 2020, Ortho Dermatologics announced the launch of first, non-reimbursed, prescription program in dermatology, telemedicine platform on dermatology.com in the U.S. This will help the patients to consult with physicians, doctors and order branded dermatology products available on the website. This will help the company to expand its business and make the product profile strong.

The company has global presence in the U.S.

FOUNDATION CONSUMER HEALTHCARE

FOUNDATION CONSUMER HEALTHCARE headquartered in Pittsburgh, Pennsylvania, was founded in year 2014. The company is engaged in developing a portfolio of over the counter products to improve the consumer’s life. The company offers wide range of product in various categories such as Plan B One –Step, Campho Phenique, St Joseph Low Dose Aspirin, Bronkaid out of which Campho Phenique is market focused category.

  • In October 2020, FOUNDATION CONSUMER HEALTHCARE acquired seven brands from GSK Consumer Healthcare via its Foundation Consumer Brands Company which is under common management of FOUNDATION CONSUMER HEALTHCARE. With this acquisition, the company is focusing on increasing its product portfolio and penetrating the OTC market.

The company has wide global presence in North America, Europe, Asia-Pacific and Middle East and Africa.